Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension

BACKGROUND: Recent studies have revealed that sustained ingestion of angiotensin converting enzymes inhibitors or angiotensin receptor blockers (ACEIs/ARBs) had no harmful effects on coronavirus disease 2019 (COVID-19) patients complicated with hypertension. AIM: To investigate the impact on COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Ci, Li, Nan, Bai, Yi, Xiao, Han, Li, Shu, Ge, Qing-Gang, Shen, Ning, Ma, Qing-Bian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809663/
https://www.ncbi.nlm.nih.gov/pubmed/33511171
http://dx.doi.org/10.12998/wjcc.v9.i1.47

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7809663/
https://www.ncbi.nlm.nih.gov/pubmed/33511171
http://dx.doi.org/10.12998/wjcc.v9.i1.47

Ejemplares similares